HSA — authorised 22 December 1997
- Marketing authorisation holder: ABBVIE
- Status: likely_approved
HSA authorised Teveten on 22 December 1997
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 22 December 1997.
ABBVIE holds the Singaporean marketing authorisation.